156 related articles for article (PubMed ID: 25927411)
41. Detection of coralyne and heparin by polymerase extension reaction using SYBR Green I.
Ma C; Chen M; He H; Chen L
Mol Cell Probes; 2019 Aug; 46():101423. PubMed ID: 31323319
[TBL] [Abstract][Full Text] [Related]
42. Contaminated heparin associated with adverse clinical events and activation of the contact system.
Kishimoto TK; Viswanathan K; Ganguly T; Elankumaran S; Smith S; Pelzer K; Lansing JC; Sriranganathan N; Zhao G; Galcheva-Gargova Z; Al-Hakim A; Bailey GS; Fraser B; Roy S; Rogers-Cotrone T; Buhse L; Whary M; Fox J; Nasr M; Dal Pan GJ; Shriver Z; Langer RS; Venkataraman G; Austen KF; Woodcock J; Sasisekharan R
N Engl J Med; 2008 Jun; 358(23):2457-67. PubMed ID: 18434646
[TBL] [Abstract][Full Text] [Related]
43. [Capillary electrophoresis analysis of contaminants in heparin sodium for the Japanese pharmacopoeia purity test].
Kakoi N; Kinoshita M; Kawasaki N; Yamaguchi T; Hayakawa T; Kakehi K
Yakugaku Zasshi; 2009 Oct; 129(10):1255-64. PubMed ID: 19797882
[TBL] [Abstract][Full Text] [Related]
44. Highly sensitive potentiometric strip test for detecting high charge density impurities in heparin.
Kang Y; Gwon K; Shin JH; Nam H; Meyerhoff ME; Cha GS
Anal Chem; 2011 May; 83(10):3957-62. PubMed ID: 21500820
[TBL] [Abstract][Full Text] [Related]
45. Oversulfated chondroitin sulfate and OSCS-contaminated heparin cause dose- and route-dependent hemodynamic effects in the rat.
Corbier A; Le Berre N; Rampe D; Meng H; Lorenz M; Vicat P; Potdevin S; Doubovetzky M
Toxicol Sci; 2011 Jun; 121(2):417-27. PubMed ID: 21436127
[TBL] [Abstract][Full Text] [Related]
46. Analysis of heparin sodium by SAX/HPLC for contaminants and impurities.
Trehy ML; Reepmeyer JC; Kolinski RE; Westenberger BJ; Buhse LF
J Pharm Biomed Anal; 2009 Apr; 49(3):670-3. PubMed ID: 19167854
[TBL] [Abstract][Full Text] [Related]
47. Crude Heparin Preparations Unveil the Presence of Structurally Diverse Oversulfated Contaminants.
Mendes A; Meneghetti MCZ; Palladino MV; Justo GZ; Sassaki GL; Fareed J; Lima MA; Nader HB
Molecules; 2019 Aug; 24(16):. PubMed ID: 31426507
[TBL] [Abstract][Full Text] [Related]
48. Determination of Oversulphated Chondroitin Sulphate and Dermatan Sulphate in unfractionated heparin by (1)H-NMR - Collaborative study for quantification and analytical determination of LoD.
McEwen I; Mulloy B; Hellwig E; Kozerski L; Beyer T; Holzgrabe U; Wanko R; Spieser JM; Rodomonte A
Pharmeuropa Bio; 2008 Dec; 2008(1):31-9. PubMed ID: 19220979
[TBL] [Abstract][Full Text] [Related]
49. Electrophoresis for the analysis of heparin purity and quality.
Volpi N; Maccari F; Suwan J; Linhardt RJ
Electrophoresis; 2012 Jun; 33(11):1531-7. PubMed ID: 22736353
[TBL] [Abstract][Full Text] [Related]
50. Label-free fluorescence detection of microRNA based on target induced adenosine2-coralyne-adenosine2 formation.
Li JJ; Xi Q; Du WF; Yu RQ; Jiang JH
Analyst; 2016 Apr; 141(8):2384-7. PubMed ID: 26998900
[TBL] [Abstract][Full Text] [Related]
51. Fluorescence detection of coralyne and polyadenylation reaction using an oligonucleotide-based fluorogenic probe.
Lin YH; Tseng WL
Chem Commun (Camb); 2011 Oct; 47(39):11134-6. PubMed ID: 21897954
[TBL] [Abstract][Full Text] [Related]
52. Review: contaminants in heparin: review of the literature, molecular profiling, and clinical implications.
Ramacciotti E; Clark M; Sadeghi N; Hoppensteadt D; Thethi I; Gomes M; Fareed J
Clin Appl Thromb Hemost; 2011 Apr; 17(2):126-35. PubMed ID: 21288929
[TBL] [Abstract][Full Text] [Related]
53. Design of two and three input molecular logic gates using non-Watson-Crick base pairing-based molecular beacons.
Lin JH; Tseng WL
Analyst; 2014 Mar; 139(6):1436-41. PubMed ID: 24490204
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of Taq polymerase as a method for screening heparin for oversulfated contaminants.
Tami C; Puig M; Reepmeyer JC; Ye H; D'Avignon DA; Buhse L; Verthelyi D
Biomaterials; 2008 Dec; 29(36):4808-14. PubMed ID: 18801571
[TBL] [Abstract][Full Text] [Related]
55. The effect of increasing the sulfation level of chondroitin sulfate on anticoagulant specific activity and activation of the kinin system.
Hogwood J; Naggi A; Torri G; Page C; Rigsby P; Mulloy B; Gray E
PLoS One; 2018; 13(3):e0193482. PubMed ID: 29494632
[TBL] [Abstract][Full Text] [Related]
56. Assessment of oversulfated chondroitin sulfate in low molecular weight and unfractioned heparins diffusion ordered nuclear magnetic resonance spectroscopy method.
Sitkowski J; Bednarek E; Bocian W; Kozerski L
J Med Chem; 2008 Dec; 51(24):7663-5. PubMed ID: 19055319
[TBL] [Abstract][Full Text] [Related]
57. Orthogonal analytical approaches to detect potential contaminants in heparin.
Guerrini M; Zhang Z; Shriver Z; Naggi A; Masuko S; Langer R; Casu B; Linhardt RJ; Torri G; Sasisekharan R
Proc Natl Acad Sci U S A; 2009 Oct; 106(40):16956-61. PubMed ID: 19805108
[TBL] [Abstract][Full Text] [Related]
58. The use of SAX-HPLC-CD as a heparin screening strategy.
Chmielewski AJ; Stanley FE; Stalcup AM
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(25):2619-23. PubMed ID: 21831728
[TBL] [Abstract][Full Text] [Related]
59. [Anaphylactoid reactions associated with contaminated heparin from China].
Montpas N; Désormeaux A; Keire D; Adam A
Ann Pharm Fr; 2011 Sep; 69(5):258-64. PubMed ID: 21924126
[TBL] [Abstract][Full Text] [Related]
60. Case study: contamination of heparin with oversulfated chondroitin sulfate.
Chess EK; Bairstow S; Donovan S; Havel K; Hu P; Johnson RJ; Lee S; McKee J; Miller R; Moore E; Nordhaus M; Ray J; Szabo C; Wielgos T
Handb Exp Pharmacol; 2012; (207):99-125. PubMed ID: 22566223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
